Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · October 24, 2023

Outcomes of Cloxacillin Plus Fosfomycin vs Cloxacillin Alone in Patients With Methicillin-Susceptible Staphylococcus Aureus Bacteremia

Nature Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Medicine
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Nat. Med. 2023 Oct 02;29(10)2518-2525, S Grillo, M Pujol, JM Miró, J López-Contreras, G Euba, O Gasch, L Boix-Palop, MJ Garcia-País, MT Pérez-Rodríguez, S Gomez-Zorrilla, I Oriol, LE López-Cortés, ML Pedro-Botet, R San-Juan, JM Aguado, F Gioia, S Iftimie, L Morata, A Jover-Sáenz, G García-Pardo, B Loeches, Á Izquierdo-Cárdenas, AJ Goikoetxea, A Gomila-Grange, B Dietl, D Berbel, S Videla, P Hereu, A Padullés, N Pallarès, C Tebé, G Cuervo, J Carratalà

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading